Skip to main content

An apple a day keeps the doctor away - but it will cost you!

On the heals of the Atul Gawande piece in the New Yorker, Dr. Abraham Vergese wrote an interesting cover article today in the Wall Street Journal on the Myth of Prevention. It is more of a thought piece then something that tries to make a clear and persuasive argument. The main point he tries to make is that “preventative medicine” promoting drugs and tests like coronary artery calcium scans won’t actually result in cost savings. Screening tests will only find conditions that will require further testing, retesting, and life-long therapies that may only benefit a small subset of patients (think PSAs in the elderly). He argues that the only way to control costs is by government wielding greater influence in health care. This is not a novel view point by any means but it is a stance that is a rarity to find in the Wall Street Journal.

 More intriguing though was a short discussion on how Medicare’s reimbursement scheme is partly to blame for what President Obama called “a system of incentives where the more tests and services are provided, the more money we pay." A system, as Dr. Vergese puts it, that “pays generously when you do something to a patient, but is stingy when you do something for a patient.” We all know interventions are the key to high reimbursement - not active case management or spending time with patients to find out their goals and values. A sustainable future for both geriatrics and palliative care may lie in correcting these incentives, or by learning how to do botox.

Comments

ken covinsky said…
Amen! Medicare is getting what it pays for.

The primary "procedure" of Geriatrics and Palliative Care is talking with our patients. Contrary to popular belief, doing this well is a complex "procedure" that takes time and skill. It is pretty striking how physicians who do this well make such a difference for their patients. It is not uncommon to see a care plan completely change based on a careful patient centered history. More often than not, this results in doing less TO patients, but doing a lot more FOR them.

Maybe one day Medicare will start viewing spending time with patients as something of value.

Popular posts from this blog

Geroscience and it's Impact on the Human Healthspan: A podcast with John Newman

Ok, I'll admit it. When I hear the phrase "the biology of aging" I'm mentally preparing myself to only understand about 5% of what the presenter is going to talk about (that's on a good day).  While I have words like telomeres, sirtuins, or senolytics memorized for the boards, I've never been able to see how this applies to my clinical practice as it always feels so theoretical.  Well, today that changed for me thanks to our podcast interview with John Newman, a "geroscientist" and geriatrician here at UCSF and at the Buck Institute for Research on Aging.

In this podcast, John breaks down what geroscience is and how it impacts how we think about many age-related conditions and diseases. For example, rather than thinking about multimorbidity as the random collection of multiple different clinical problems, we can see it as an expression of the fundamental mechanisms of aging. This means, that rather than treating individuals diseases, targeting …

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …

Length of Stay in Nursing Homes at the End of Life

One out of every four of us will die while residing in a nursing home. For most of us, that stay in a nursing home will be brief, although this may depend upon social and demographic variables like our gender, net worth, and marital status. These are the conclusions of an important new study published in JAGS by Kelly and colleagues (many of whom are geripal contributors, including Alex Smith and Ken Covinsky).

The study authors used data from the Health and Retirement Study (HRS) to describe the lengths of stay of older adults who resided in nursing homes at the end of life. What they found was that out of the 8,433 study participants who died between 1992 and 2006, 27.3% of resided in a nursing home prior to their death. Most of these patients (70%) actually died in the nursing home without being transferred to another setting like a hospital.

 The length of stay data were striking:

the median length of stay in a nursing home before death was 5 months the average length of stay was l…